Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 3:31 pm Purchase | 2024-12-31 | 13G | MDxHealth S.A. MDXH | Lytton, Laurence W. | 3,949,385 8.400% | 1,058,790 (+36.63%) | Filing History |
| 2025-02-13 3:26 pm Sale | 2024-12-31 | 13G | EMCORE Corporation EMKR | Lytton, Laurence W. | 126,948 1.400% | -359,537 (-73.91%) | Filing History |
| 2025-02-05 4:16 pm Purchase | 2025-01-30 | 13G | Sonim Technologies, Inc. SONM | Lytton, Laurence W. | 465,516 9.600% | 465,516 (New Position) | Filing History |
| 2024-12-23 6:52 pm Purchase | 2024-12-20 | 13G | SmartKem, Inc. SMTK | Lytton, Laurence W. | 333,333 9.400% | 333,333 (New Position) | Filing History |
| 2024-12-23 6:51 pm Purchase | 2024-12-17 | 13G | Electrovaya Inc. ELVA | Lytton, Laurence W. | 2,443,309 6.200% | 2,443,309 (New Position) | Filing History |
| 2024-11-26 08:42 am Purchase | 2024-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC | Lytton, Laurence W. | 2,059,922 6.600% | 755,820 (+57.96%) | Filing History |
| 2024-11-14 3:58 pm Purchase | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | Lytton, Laurence W. | 2,944,932 5.900% | 1,119,698 (+61.35%) | Filing History |
| 2024-11-14 1:26 pm Purchase | 2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | Lytton, Laurence W. | 146,332 9.990% | 36,993 (+33.83%) | Filing History |
| 2024-11-14 1:23 pm Purchase | 2024-09-30 | 13G | Stryve Foods, Inc. SNAX | Lytton, Laurence W. | 240,688 7.600% | 45,908 (+23.57%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Giga-tronics Incorporated GIGA | Lytton, Laurence W. | 682,688 8.400% | 74,511 (+12.25%) | Filing History |
| 2024-11-14 1:20 pm Sale | 2024-09-30 | 13G | Scientific Industries, Inc. SCND | Lytton, Laurence W. | 1,067,946 9.990% | -15,953 (-1.47%) | Filing History |
| 2024-11-14 1:17 pm Sale | 2024-09-30 | 13G | Rail Vision Ltd. RVSN | Lytton, Laurence W. | 60,679 0.300% | -389,321 (-86.52%) | Filing History |
| 2024-11-14 1:15 pm Purchase | 2024-09-30 | 13G | EMCORE Corporation EMKR | Lytton, Laurence W. | 486,485 5.400% | 486,485 (New Position) | Filing History |
| 2024-11-14 1:13 pm Purchase | 2024-09-30 | 13G | Biofrontera Inc. BFRI | Lytton, Laurence W. | 554,884 9.990% | 45,998 (+9.04%) | Filing History |
| 2024-11-14 1:08 pm Purchase | 2024-09-30 | 13G | Evoke Pharma, Inc. EVOK | Lytton, Laurence W. | 74,757 9.990% | 74,757 (New Position) | Filing History |
| 2024-11-14 1:06 pm Purchase | 2024-09-30 | 13G | TELA Bio, Inc. TELA | Lytton, Laurence W. | 2,452,257 9.900% | 1,112,205 (+83.00%) | Filing History |
| 2024-11-14 1:05 pm Sale | 2024-09-30 | 13G | CalciMedica, Inc. CALC | Lytton, Laurence W. | 468,943 4.400% | -287,237 (-37.99%) | Filing History |
| 2024-11-14 1:03 pm Purchase | 2024-09-30 | 13G | Acutus Medical, Inc. AFIB | Lytton, Laurence W. | 2,078,030 7.000% | 331,207 (+18.96%) | Filing History |
| 2024-11-14 12:59 pm Sale | 2024-09-30 | 13G | Duos Technologies Group, Inc. DUOT | Lytton, Laurence W. | 400,568 5.200% | -82,408 (-17.06%) | Filing History |
| 2024-11-14 12:56 pm Sale | 2024-09-30 | 13G | Azitra, Inc. AZTR | Lytton, Laurence W. | 0 0.000% | -369,985 (Position Closed) | Filing History |